Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma

World Journal of Gastroenterology

Volumn 16, Issue 13, 2010, Pages 1649-1654

  Lv, Jin ^a   Cao, Xiu Feng ^a   Zhu, Bin ^a   Ji, Lv ^a   Tao, Lei ^a   Wang, Dong Dong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Esophageal cancer; Esophagectomy; Radiation therapy; Surgery

Indexed keywords

CISPLATIN; PACLITAXEL;

ACUTE LUNG INJURY; ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PROGRESSION FREE SURVIVAL; RADIATION INDUCED EMESIS; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; THROMBOCYTOPENIA; VOMITING;

EID: 77950898018     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i13.1649     Document Type: Article

References (20)

1. Cao XF, He XT, Ji L, Xiao J, Lv J. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus 2009; 22: 477-481.
2. Graham AJ, Shrive FM, Ghali WA, Manns BJ, Grondin SC, Finley RJ, Clifton J. Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg 2007; 83: 1257-1264.
3. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol 2009; 15: 4962-4968.
4. Ruol A, Portale G, Castoro C, Merigliano S, Cagol M, Cavallin F, Chiarion Sileni V, Corti L, Rampado S, Costantini M, Ancona E. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol 2007; 14: 3243-3250.
5. Zemanova M, Petruzelka L, Pazdro A, Kralova D, Smejkal M, Pazdrova G, Honova H. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. Dis Esophagus 2009; Epub ahead of print
6. Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Yokomakura N, Ishigami S, Owaki T, Aikou T. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus 2006; 19: 468-472.
7. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery 2005; 137: 172-177.
8. Dixit S, Tilston M, Peter WM. Risk stratification for recurrence in patients with esophageal and junctional carcinoma treated with neoadjuvant chemotherapy and surgery. Med Oncol 2009; Epub ahead of print
9. Bonnetain F, Bouché O, Michel P, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Paillot B, Arveux P, Milan C, Bedenne L. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006; 17: 827-834.
10. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
11. Di Fiore F, Lecleire S, Rigal O, Galais MP, Ben Soussan E, David I, Paillot B, Jacob JH, Michel P. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12: 4185-4190.
12. Triboulet JP, Mariette C. [Oesophageal squamous cell carcinoma stade III. State of surgery after radiochemotherapy (RCT)] Cancer Radiother 2006; 10: 456-461.
13. Iyer R, Wilkinson N, Demmy T, Javle M. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol 2004; 11: 665-673.
14. Bédard EL, Inculet RI, Malthaner RA, Brecevic E, Vincent M, Dar R. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001; 91: 2423-2430.
15. Kurtzman SM, Whittington R, Vaughn D, Rosato EF, Haller DG. Post-operative chemosensitized radiation with modulated 5-fluorouracil (5-FU) following resection of adenocar- cinoma of the esophagus and esophagogastric (EG) junction. Int J Radiat Oncol Biol Phys 1995; 32: 266
16. Kang HJ, Ebie N, Murthy AK, Galinsky DL, Tsekeris P, Griem K. Surgery followed by concomitant accelerated fractionation irradiation, cisplatin, and 5-FU for esophageal carcinoma. Proc Am Soc Clin Oncol 1992; 11: 167
17. Ebie N, Kang HJ, Millikan K, Murthy AK, Griem K, Hartsell W, Recine DC, Doolas A, Taylor S 4th. Integration of surgery in multimodality therapy for esophageal cancer. Am J Clin Oncol 1997; 20: 11-15.
18. Taylor SG, Bonomi PD, Kiel KD, Slayton RE, Wolter J. Failure of simultaneous cisplatin/5FU infusion chemotherapy and radiation to improve control of esophageal cancer. Proc Am Soc Clin Oncol 1986; 5: 88
19. Saito T, Shigemitsu Y, Kinoshita T, Shimoda K, Abe T, Nakamura A, Chikuba K, Kobayashi M. Cisplatin, vindesine, pepleomycin and concurrent radiation therapy following esophagectomy with lymph adenectomy for patients with an esophageal carcinoma. Oncology 1993; 50: 293-297.
20. Rice TW, Adelstein DJ, Chidel MA, Rybicki LA, DeCamp MM, Murthy SC, Blackstone EH. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003; 126: 1590-1596